IP Cases — 2024
6,517 decisions across all jurisdictions
Page 180 of 218 · 6,517 total
Apple Inc. v.DH International Ltd
Apple successfully petitioned the PTAB to institute an IPR against DH International Ltd's patent, arguing that the claims are obvious over Suga in view of Gorsuch. The Board preliminarily construed key terms like 'invariable activation command,' finding a reasonable likelihood of unpatentability for the challenged claims.
Apple Inc. v.DH International Ltd
The PTAB determined that all 20 challenged claims of the '294 patent were unpatentable under 35 U.S.C. § 103, finding obviousness over combinations of Suga and Gorsuch. The Board successfully rejected the Patent Owner's attempts to narrow key claim terms, upholding the Petitioner's broad interpretation of functional language.
Crystal Crop Protection Limited v.Safex Chemicals India Limited & Ors
The Plaintiff alleges that the Defendants' product composition infringes on their patented weedicidal formulation, which includes a specific blend of chemicals. The case involves determining whether the Defendants' product violates the claims of the Plaintiff's patent.
Hygieia, Inc. v.Assistant Controller of Patents and Designs, Government of India
Hygieia appealed the rejection of its patent application (No. 10225/CHENP/2013) by the Assistant Controller of Patents and Designs. The rejection was based on various grounds, including Section 59, which alleged that the amended claims exceeded the original specification. The Madras High Court allowed the appeal, emphasizing that a patent specification must be read as a whole.
Levi Strauss & Company v.Inder Mohan Chadha
Levi Strauss & Company filed a suit against Inder Mohan Chadha for infringement of its well-known trademarks, including 'Levi's' and the Two Horse logo. The plaintiff alleged that the defendant was clandestinely stocking, distributing, and selling apparels bearing falsified marks identical or deceptively similar to those registered by Levi Strauss & Company.
Eli Lilly And Company Private Limited v.Eskayef Pharmaceuticals Limited
Plaintiffs, Eli Lilly And Company, filed a suit alleging infringement of their Indian Patent No. IN 297760 (covering Abemaciclib) by the Impugned Drug 'Abeclib', manufactured by Defendant No. 1. The court prima facie found that 'Abeclib' infringes the patent and granted an interim injunction.
Business Objects Software Limited v.The Controller of Patents
Business Objects Software Limited appealed an order by The Controller of Patents rejecting its invention, titled 'Transparent Distribution and Module Decoupling Through Asynchronous Communication and Scopes', under Section 2(1)(j) of the Patent Act. The High Court found that the Controller's order lacked quality and failed to consider the appellant's amended claims during the hearing.
Wyeth Llc v.The Controllers Of Patents
Wyeth LLC appealed an impugned order regarding its patent application. The core dispute revolves around amendments made by the appellant from a PCT application (claiming a 'regimen') to subsequent national phase applications (claiming a 'combination' and 'pharmaceutical pack'). Wyeth argues these amendments were within the scope of Section 59 of the Patents Act, 1970.
Novartis Ag & Ors. v.Noviets Pharma & Ors.
The Delhi High Court addressed several interlocutory applications in the trademark infringement dispute between Novartis Ag & Ors. and Noviets Pharma & Ors. The court allowed the plaintiffs to file additional documents and granted an exemption from mandatory pre-suit mediation. Crucially, the court formally registered the plaint as a suit, setting out detailed procedural timelines for filing written statements, replications, and affidavits of admission/denial, while also addressing the preliminary injunction application seeking restraint against trademark infringement.
Nababuddin Ahmed v.The Registrar Of Trademarks Kolkata And Anr
The Calcutta High Court ruled in favor of Nababuddin Ahmed, setting aside the unauthorized removal of his registered trademark. The court held that merely uploading a notice on an official website does not constitute valid service under Section 25 of the Trade Marks Act, 1999. Since the petitioner was not given individual notice and opportunity to rectify defects, the administrative action taken by the Registrar was deemed vitiated.
Netgear Inc., Netgear Deutschland GmbH, Netgear International Limited v.Huawei Technologies Co. Ltd
The Court of Appeal of the Unified Patent Court addressed an appeal by Netgear concerning the deadline for filing a Statement of Defense after Huawei extended its infringement action to include a second patent (EP 3678321). The Court held that due process requires the defendant to have the same time to respond to an added patent as if a new action had been filed, and set the defense deadline to April 18, 2024, running from the date of the Local Division's confirmation order (January 18, 2024) rather than from the earlier judge-rapporteur's order.
10x Genomics, Inc. v.Curio Bioscience Inc.
Unified Patent Court decision.
NanoString Technologies Inc., NanoString Technologies Germany GmbH, and NanoString Technologies Netherlands B.V. v.President and Fellows of Harvard College and 10x Genomics, Inc.
This appeal concerned a request for provisional measures (a cease-and-desist order) by 10x Genomics and Harvard College against NanoString Technologies for alleged infringement of European patent EP 4 108 782, which relates to compositions and methods for analyte detection. The Court of First Instance (Munich Local Division) had granted the injunction, but on appeal, the Court of Appeal revoked the orders and rejected the Applicants' request, finding that the Applicants had not established the required sufficient degree of certainty regarding validity and infringement. The Applicants were ordered to bear the costs of the proceedings.
Netgear Inc., Netgear Deutschland GmbH, Netgear International Limited v.Huawei Technologies Co. Ltd
This is an appeal before the Court of Appeal of the Unified Patent Court concerning the deadline for a defendant's response after a claim extension adding a new patent (EP 3678321) to an already pending infringement action. The Court of Appeal held that due process requires the defendant to have the same time to respond to the newly added patent as if a new action had been filed, and set aside the Court of First Instance's ruling that the response period began on December 11, 2023, instead fixing the deadline at April 18, 2024.
NanoString Technologies Germany GmbH, NanoString Technologies Netherlands B.V. and NanoString Technologies Inc. v.10x Genomics, Inc. and President and Fellows of Harvard College
This is a corrigendum issued by the Court of Appeal of the Unified Patent Court on 11 March 2024, correcting Headnote 2, paragraph 3 of its earlier order dated 26 February 2024 in proceedings concerning EP 4 108 782. The underlying proceedings concern an appeal against an order of the Court of First Instance (Local Chamber Munich) of 19 September 2023 in provisional measures proceedings (UPC CFI 2/2023). The corrected headnote sets out principles for the interpretation of European patent claims under Article 69 EPC in conjunction with the Protocol on its interpretation.
Pfizer Inc. v.Beacon Pharmaceuticals Limited
The case involves a patent infringement dispute where Pfizer Inc. claims that Beacon Pharmaceuticals has infringed on their patents. An ex-parte ad-interim injunction was granted in favor of the Plaintiffs regarding the subsisting patents.
Diageo North America, Inc v.Venkateshwara Winery & Distillary Pvt. Ltd.
Diageo North America filed a petition seeking rectification (cancellation) of the trademark 'BULLET MALTED WHISKY' registered by Venkateshwara Winery & Distillary Pvt. Ltd., alleging that it is deceptively similar to Diageo's well-known mark 'BULLEIT'. The court allowed the petition, finding that the petitioner had established a case for cancellation.
Kao Corporation v.The Controller Of Patents & Anr.
Kao Corporation appealed a rejection order issued by the Controller of Patents concerning its patent application No. 5945/DELNP/2009. The appellant argued that the Controller's observation contradicted previous hearing notices and written submissions, specifically regarding industrial applicability under Section 2(1)(ac) of the Patents Act, 1970.
Bdr Pharmaceuticals International Pvt Ltd v.Kudos Pharmaceuticals Limited & Anr
This order addresses an interim injunction application filed by Kudos Pharmaceuticals Limited (Plaintiff) against Bdr Pharmaceuticals International Pvt Ltd (Defendant). The court noted that the suit patent IN'720 was nearing its expiration date. The parties debated whether to proceed with the hearing given the imminent expiry and broader legal questions regarding patent coverage versus disclosure.
Martinswerk Gmbh v.The Assistant Controller of Patents and Designs, Government of India
Martinswerk Gmbh appealed the rejection of its product patent application for novel aluminum hydroxide flame retardants. The appeal argued that the Patent Controller repeatedly shifted and reverted between different limbs of Section 3(d) without providing a consistent or fair hearing process. The High Court found merit in these submissions.
Gm Modular Pvt Ltd. v.Mayur Electromeck Pvt Ltd.
The Delhi High Court allowed the rectification petition filed by Gm Modular Pvt Ltd., successfully challenging the registration of a similar mark held by Mayur Electromeck Pvt Ltd. The court found that the Impugned Mark was not genuinely used in commerce, despite the respondent's claims. Based on the lack of substantial evidence of use and potential confusion with the established 'GM' brand, the High Court ordered the cancellation of the infringing trademark registration.
Runergy Alabama Inc et al. v.Trina Solar Co. Ltd.
Runergy and its affiliates have filed a joint motion with Trina Solar and Evervolt to terminate their participation in IPR2025-00006 after settling all disputes, including a related ITC proceeding.
Runergy Alabama Inc et al. v.Trina Solar Co. Ltd.
Runergy has filed an IPR petition seeking cancellation of all 17 claims of Trina Solar’s 009 patent, asserting obviousness over multiple prior‑art references covering TOPCon solar cell structures.
Runergy Alabama Inc et al. v.Trina Solar Co. Ltd.
The PTAB institution decision granted the petitioner a reasonable likelihood of prevailing on all challenged claims related to solar cell technology. The grounds for obviousness centered on combining prior art references like Jin and Feldmann to achieve predictable improvements in TOPCon structure efficiency.
Runergy Alabama Inc et al. v.Trina Solar Co. Ltd.
The Petitioner successfully demonstrated that all 17 challenged claims are unpatentable under 35 U.S.C. § 103(a). The Board found specific combinations of prior art, notably Chang and Jin, rendered the claimed solar cell structures obvious.
Avation Medical, Inc. v.EMKinetics, Inc.
EMKinetics challenges the PTAB’s Final Written Decision that invalidated 13 claims of U.S. Patent 11,224,742, arguing the Board relied on unsupported presumptions of public accessibility and improperly admitted new evidence as rebuttal. The Patent Owner seeks Director Review to vacate the decision.
Avation Medical, Inc. v.EMKinetics, Inc.
Avation Medical’s IPR resulted in claims 1‑13 of U.S. Patent 11,224,742 being found unpatentable. EMKinetics sought Director Review, re‑asserting printed‑publication arguments, but the Board denied the request, upholding its decision.
Avation Medical, Inc. v.EMKinetics, Inc.
Avation Medical has filed an IPR petition challenging EMKinetics' U.S. Patent 11,224,742 covering non‑invasive posterior tibial nerve stimulation for overactive bladder. The petition argues the claims are obvious over prior‑art references such as Svihra, Amarenco, Mann and Ponsford and seeks institution of the trial.
Avation Medical, Inc. v.EMKinetics, Inc.
Avation Medical successfully secured the institution of its IPR against EMKinetics, challenging claims 1-13 based on obviousness over combinations of prior art. The Board found that Petitioner adequately supported unpatentability by demonstrating skilled artisans could make the claimed modifications to existing nerve stimulation methods.
Avation Medical, Inc. v.EMKinetics, Inc.
The PTAB found all 13 challenged claims unpatentable under 35 U.S.C § 103. The Board concluded that the claimed nerve stimulation therapy was obvious over combinations of prior art, specifically citing modifications to Svihra and Amarenco using Mann and Ponsford. This decision confirms the lack of inventive step for the technology described in the patent.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.